Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-19
2006-12-19
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S517000
Reexamination Certificate
active
07151098
ABSTRACT:
The present invention is a compound of formulawhereinX is an ethynediyl group, R1, R2and R3are as defined in the specification.
REFERENCES:
patent: 5716953 (1998-02-01), Donati et al.
patent: 6051712 (2000-04-01), Binggeli et al.
patent: 6407094 (2002-06-01), Adam et al.
patent: 6544985 (2003-04-01), Adam et al.
patent: 6548495 (2003-04-01), Adam et al.
patent: 6949542 (2005-09-01), Adam et al.
patent: 0487155 (1992-05-01), None
patent: 60-32775 (1985-02-01), None
patent: 62174062 (1987-07-01), None
patent: 4-283572 (1992-10-01), None
patent: WO 92/03438 (1992-03-01), None
patent: WO 94/03437 (1994-02-01), None
patent: WO 96/05818 (1996-02-01), None
patent: WO 97/05109 (1997-02-01), None
patent: WO 99/26927 (1999-06-01), None
patent: WO 01/29011 (2001-04-01), None
patent: WO 01/29012 (2001-04-01), None
Cartmell, et al. Br. J. Pharmacol. 1998, vol. 123(3) pp. 497-504.
Wilson, J., et al., J. Chem. 1983, vol. 36, pp. 2317-2325.
Giroux et al., Tetr. Lett. 1997, vol. 38, pp. 3841-3844.
Ishiyama et al., Tetr. Lett. 1993, vol. 34, pp. 7595-7598.
Kosugi et al., Bull. Chem. Soc. Jpn. 1983, vol. 56, pp. 3855-3856.
Thorand et al., J. Org. Chem. 1998, vol. 63, pp. 8551-8553.
Bellamy et al., Tetr. Lett. 1984, vol. 25 pp. 839-842.
Rathke et al. Synth. Commun. 1985, vol. 15 pp. 1039-1049.
Hagedorn et al., J. Med. Chem. 1987, vol. 30, pp. 1342-1347.
Park, et al., Tetrahedron, 1984, vol. 40, pp. 2985-2988.
Hiromichi et al., Chem. Pharm. Bull. 1983, vol. 31, pp. 1896-1901.
Winkler et al., Tetrahedron Lett., 1998, vol. 39, pp. 2253-2256.
Masayoshi e tal., Journal of Antibiotics, 1978, vol. 31, pp. 1245-1251.
Beny et al., J. Org. Chem. 1982, vol. 47, pp. 2201-2204.
Corey et al., J. Org. Chem. vol. 38, No. 18, p. 3224, 1973.
Brauner-Osborne et al., Ligands for Glutamate Receptor: Design and Therapeutic Prospects, J. Med. Chem. vol. 43, pp. 2609-2645.
CAS Printout for JP62174062, Chem. Abstracts vol. 108:75434 (1987).
CAS Printout for Solomko et al., Chem. Abstracts vol. 102:132005.
CAS Printout for Solomko et al., Chem. Abstracts vol. 102:6436.
CAS Printout for Bougrin et al., Chem. Abstracts vol. 122:239666.
CAS Printout for Hamdi et al., Chem. Abstracts vol. 121:83303.
CAS Printout for Rao et al., Chem. Abstracts vol. 117:69839.
M. Hanumantha, Rao, et al., Synthesis vol. 5, pp. 446-448 (1992).
Chemical Abstracts 87:167993 (1977).
Tetrahedron Letters, 1994, vol. 35, No. 45, pgs. 8373-8376 (1994).
Adam Geo
Alanine Alexander
Goetschi Erwin
Mutel Vincent
Woltering Thomas Johannes
Hoffmann-La Roche Inc.
Johnston George W.
Kifle Bruck
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Glutamate receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glutamate receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamate receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714922